This study focuses on the development and assessment of a novel fast-dissolving drug formulation aimed at improving drug delivery efficiency and patient compliance. The formulation was designed to dissolve rapidly in the oral cavity, facilitating quick absorption and onset of action. Through a systematic approach, the formulation's composition, including excipients and active pharmaceutical ingredients, was optimized to achieve rapid dissolution while maintaining stability and bioavailability. Various techniques, such as direct compression, freeze-drying, and spray drying, were explored to produce the fast-dissolving drug formulation. Evaluation of the formulation involved assessments of dissolution kinetics, drug release profile, physical characteristics, and pharmacokinetic parameters. The results demonstrate the potential of the fast-dissolving drug formulation to offer enhanced drug delivery and improved patient experience, making it a promising option for pharmaceutical development.